Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

GE HealthCare Technologies Inc.

NASDAQ

Market Cap.

36.45B

Avg. Volume

3.11M

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze GE HealthCare Technologies Inc.!

Still processing it, give me a bit more time...

GE HealthCare Technologies Inc. News

GE HealthCare Technologies Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Healthcare Information Services
gehealthcare.com

About GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

GE HealthCare Technologies Inc. Earnings & Revenue

GE HealthCare Technologies Inc. Financials

Table Compare

Compare GEHC metrics with:

   

Earnings & Growth

GEHC

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

GEHC

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

GEHC

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

GEHC

None

Debt Ratio

--

--

Quick Ratio

--

--

 

GE HealthCare Technologies Inc. Income

GE HealthCare Technologies Inc. Balance Sheet

GE HealthCare Technologies Inc. Cash Flow

GE HealthCare Technologies Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Buy
Return on AssetsBuy
Debt/Equity RatioStrong Buy
Price/Earnings RatioStrong Buy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

GE HealthCare Technologies Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

0.1200

Payment DateDividendFrequency
2024-05-150.03Quarterly
2024-02-150.03Quarterly
2023-11-150.03Quarterly
2023-08-150.03Quarterly
2023-06-150.03Quarterly

Historical Market Cap

Shares Outstanding

GE HealthCare Technologies Inc. Executives

NameRole
Dr. Taha Kass-Hout M.D., M.S.Chief Science & Technology Officer
Mr. Peter J. ArduiniPresident, Chief Executive Officer & Director
Mr. Frank R. Jimenez Esq.Vice President, General Counsel & Corporate Secretary
Mr. Jan MakelaPresident & Chief Executive Officer of Imaging
Mr. James K. SaccaroVice President & Chief Financial Officer
NameRoleGenderDate of BirthPay
Dr. Taha Kass-Hout M.D., M.S.Chief Science & Technology Officer19724.61M
Mr. Peter J. ArduiniPresident, Chief Executive Officer & DirectorMale19654.29M
Mr. Frank R. Jimenez Esq.Vice President, General Counsel & Corporate SecretaryMale19652.06M
Mr. Jan MakelaPresident & Chief Executive Officer of ImagingMale19691.57M
Mr. James K. SaccaroVice President & Chief Financial OfficerMale19731.52M

GE HealthCare Technologies Inc. Insider Trades

Date21 May
NameYang Watkin Phoebe L.
RoleDirector
TransactionAcquired
TypeA-Award
Shares2440
Date21 May
NameStromberg William J
RoleDirector
TransactionAcquired
TypeA-Award
Shares2440
Date21 May
NameStromberg William J
RoleDirector
TransactionAcquired
TypeA-Award
Shares1769
Date21 May
NameMihaljevic Tomislav
RoleDirector
TransactionAcquired
TypeA-Award
Shares2440
Date21 May
NameMadden Anne T
RoleDirector
TransactionAcquired
TypeA-Award
Shares2440
DateNameRoleTransactionTypeShares
21 MayYang Watkin Phoebe L.DirectorAcquiredA-Award2440
21 MayStromberg William JDirectorAcquiredA-Award2440
21 MayStromberg William JDirectorAcquiredA-Award1769
21 MayMihaljevic TomislavDirectorAcquiredA-Award2440
21 MayMadden Anne TDirectorAcquiredA-Award2440

Discover More

Streamlined Academy

GE HealthCare Technologies Inc.

NASDAQ

Market Cap.

36.45B

Avg. Volume

3.11M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

GE HealthCare Technologies Inc. News

GE HealthCare Technologies Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

GE HealthCare Technologies Inc. Earnings & Revenue

GE HealthCare Technologies Inc. Income

GE HealthCare Technologies Inc. Balance Sheet

GE HealthCare Technologies Inc. Cash Flow

GE HealthCare Technologies Inc. Financials Over Time

GE HealthCare Technologies Inc. Executives

NameRole
Dr. Taha Kass-Hout M.D., M.S.Chief Science & Technology Officer
Mr. Peter J. ArduiniPresident, Chief Executive Officer & Director
Mr. Frank R. Jimenez Esq.Vice President, General Counsel & Corporate Secretary
Mr. Jan MakelaPresident & Chief Executive Officer of Imaging
Mr. James K. SaccaroVice President & Chief Financial Officer
NameRoleGenderDate of BirthPay
Dr. Taha Kass-Hout M.D., M.S.Chief Science & Technology Officer19724.61M
Mr. Peter J. ArduiniPresident, Chief Executive Officer & DirectorMale19654.29M
Mr. Frank R. Jimenez Esq.Vice President, General Counsel & Corporate SecretaryMale19652.06M
Mr. Jan MakelaPresident & Chief Executive Officer of ImagingMale19691.57M
Mr. James K. SaccaroVice President & Chief Financial OfficerMale19731.52M

GE HealthCare Technologies Inc. Insider Trades

Date21 May
NameYang Watkin Phoebe L.
RoleDirector
TransactionAcquired
TypeA-Award
Shares2440
Date21 May
NameStromberg William J
RoleDirector
TransactionAcquired
TypeA-Award
Shares2440
Date21 May
NameStromberg William J
RoleDirector
TransactionAcquired
TypeA-Award
Shares1769
Date21 May
NameMihaljevic Tomislav
RoleDirector
TransactionAcquired
TypeA-Award
Shares2440
Date21 May
NameMadden Anne T
RoleDirector
TransactionAcquired
TypeA-Award
Shares2440
DateNameRoleTransactionTypeShares
21 MayYang Watkin Phoebe L.DirectorAcquiredA-Award2440
21 MayStromberg William JDirectorAcquiredA-Award2440
21 MayStromberg William JDirectorAcquiredA-Award1769
21 MayMihaljevic TomislavDirectorAcquiredA-Award2440
21 MayMadden Anne TDirectorAcquiredA-Award2440

Streamlined Academy

Website screenshot
HealthcareMedical - Healthcare Information Services
gehealthcare.com

About GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze GE HealthCare Technologies Inc.!

Still processing it, give me a bit more time...

GE HealthCare Technologies Inc. Financials

Table Compare

Compare GEHC metrics with:

   

Earnings & Growth

GEHC

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

GEHC

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

GEHC

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

GEHC

None

Debt Ratio

--

--

Quick Ratio

--

--

 

GE HealthCare Technologies Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

0.1200

Payment DateDividendFrequency
2024-05-150.03Quarterly
2024-02-150.03Quarterly
2023-11-150.03Quarterly
2023-08-150.03Quarterly
2023-06-150.03Quarterly

GE HealthCare Technologies Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Buy
Return on AssetsBuy
Debt/Equity RatioStrong Buy
Price/Earnings RatioStrong Buy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More